Cellular Therapies Leading to New Treatment Options for Lymphoma Patients - Top-Institutions - MDSpire

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

A new CAR T-cell consortium, Matthew Cortese, MD, MPH, a hematologic oncologist at Roswell Park Comprehensive Cancer Center, shares that certain types of hard-to-treat lymphomas may be more receptive to immunotherapies than previously thought.

  • June 30, 2025

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, NY

    Key Differentiators

    • Hematologic Oncology
    • Cellular Therapy
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematologic Oncology
    • Cellular Therapy
    • Immunotherapy

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematologic Oncology
    • Cellular Therapy
    • Bone Marrow Transplantation

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematologic Oncology
    • Cellular Therapy
    • Immunotherapy

Original Source(s)

Cellular Therapies Leading to New Treatment Options for Lymphoma Patients

  • June 30, 2025

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Potential targets for boron transport in boron neutron capture therapy